Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27

Not Applicable

Completed

• Conditions: Skin Toxicity
• Interventions: Device: sunbed exposure

• Registration Number: NCT01976481
• Lead Sponsor: University of Zurich

Brief Summary

Our study aims to clarify the impact of the use of a standard sunbed according to new EU guideline EN 60335-2-27 and possibly discount the positive effects of tanning beds. We plan to investigate the serum elevation of 25(OH)D under sunbed use, respecting the new recommendations for the exposure plan for different skin types according to EN 60335-2-27.

The use of a sunbed will be compared to a control group not using a sunbed in the observation period.

* Trial with medical device

Detailed Description

We will compare to baseline changes in serum vitamin D and health-related quality of life using a control group and an intervention group.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2013-10-29
• Study First Submitted QC: 2013-10-29
• Study Start: 2013-11
• Study First Posted: 2013-11-05
• Primary Completion: 2014-12
• Status Verified: 2015-08
• Study Completion: 2015-08
• Last Update Submitted: 2016-08-02
• Last Update Posted: 2016-08-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Sunbed	sunbed exposure	sunbed exposure

Primary Outcome Measures

Name	Time	Method
Determination of number of patients with a relevant elevation of serum 25-hydroxyvitamin D levels of =10ug/L from the baseline	six months

Trial Locations

Locations (1)

University Hospital Zurich, Division of Dermatology; 🇨🇭 Zurich, ZH, Switzerland